André S., Kaltner H., Lensch M., Russwurm R., Siebert H.C., Fallsehr C., Tajkhorshid E., Heck A.J., von Knebel Doeberitz M., Gabius H.J. and Kopitz J. (2005). Determination of structural and functional overlap/divergence of five proto-type galectins by analysis of the growth-regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells. Int. J. Cancer 114, 46-57
André S., Pei Z., Siebert H-C., Ramström O. and Gabius H.J. (2006). Glycosyldisulfides from dynamic combinatorial libraries as O-glycoside mimetics for plant and endogenous lectins: their reactivities in solid-phase and cell assays and conformational analysis by molecular dynamics simulations. Bioorg. Med. Chem. 14, 6314-6326
André S., Sanchez-Ruderisch H., Nakagawa H., Buchholz M., Kopitz J., Forberich P., Kemmner W., Böck C., Deguchi K., Detjen K.M., Wiedenmann B., von Knebel Doeberitz M., Gress T.M., Nishimura S., Rosewicz S. and Gabius H.J. (2007). Tumor suppressor p16INK4a - modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J. 274, 3233-3256.
Arida M., Barnes E.L. and Hunt J.L. (2005). Molecular assessment of allelic loss in Warthin's tumors. Mod. Pathol. 18, 964-968.
Čada Z., Chovanec M., Smetana K. Jr, Betka J., Lancia L., Plzák J., Kodet R., Štork J., Lensch M., Kaltner H., André S. and Gabius H-J. (2009). Galectin-7: will the lectin's activity establish clinical correlations in head and neck squamous cell and basal cell carcinomas? Histol. Histopathol. 24, 41-48.
Chapnik J.S. (1983). The controversy of Warthin's tumor. Laryngoscope 93, 695-716.
Danguy A., Rorive S., Decaestecker C., Bronckart Y., Kaltner H., Hadari Y.R., Goren R., Zich Y., Petein M., Salmon I., Gabius H.J. and Kiss R. (2001) Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system. Histol. Histopathol. 16, 861-868.
Delorge S., Saussez S., Pelc P., Devroede B., Marchant H., Burchert M., Zeng F.Y., Danguy A., Salmon I., Gabius H-J., Kiss R. and Hassid S. (2000). Correlation of galectin-3/galectin-3-binding sites with low differentiation status in head and neck squamous cell carcinomas. Otolaryngol. Head Neck Surg. 122, 834-841.
Ferrazzo K.L., Alves S.M. Jr, Santos E., Martins M.T. and de Sousa S.M. (2007). Galectin-3 immunoprofile in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. Oral Oncol. 43, 580-585.
Gabius H-J. (2009) The sugar code. Fundamentals of glycosciences. Wiley-VCH. Weinheim, Germany
Kayer K., Hoeft D. and Hufnagl P. (2003). Combined analysis of tumor growth pattern and expression of endogenous lectins as a prognostic tool in primary testicular cancer and its lung metastases. Histol. Histopathol. 18, 771-779.
Kopitz J., André S., von Reitzenstein C., Versluis K., Kaltner H., Pieters R.J., Wasano K., Kuwabara I., Liu F.T., Cantz M., Heck A.J. and Gabius H.J. (2003). Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene 22, 6277-6288
Lacina L., Smetana K. Jr, Dvoránková B., Pytlík R., Kideryová L., Kucerová L., Plzáková Z., Stork J., Gabius H.J. and André S. (2007). Stromal fibroblasts from basal cell carcinoma affect phenotype of normal keratinocytes. Br. J. Dermatol. 156, 819-829.
Langbein S., Brade J., Badawi J.K., Hatzinger M., Kaltner H., Lensch M., Specht K., André S., Brinck U., Alken P. and Gabius H.J. (2007). Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Histopathology 51, 681-690.
Maiorano E., Lo Muzio L., Favia G. and Piattelli A. (2002). Warthin's tumour: a study of 278 cases with emphasis on bilaterality, multifocality and association with other malignancies. Oral Oncol. 38, 35-40.
Nagy N., Bronckart Y., Camby I., Legendre H., Lahm H., Kaltner H., Hadari Y., Van Ham P., Yeaton P., Pector J.C., Zick Y., Salmon I., Danguy A., Kiss R. and Gabius H.J. (2002). Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut 50, 392-401.
Nagy N., Legendre H., Engels O., André S., Kaltner H., Wasano K., Zick Y., Pector J.C., Decaestecker C., Gabius H.J., Salmon I. and Kiss R. (2003). Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer 97, 1849-1858.
Plzák J., Betka J., Smetana K. Jr., Chovanec M., Kaltner H., André S., Kodet R. and Gabius H-J. (2004). Galectin-3: an emerging prognostic indicator in advanced head and neck carcinoma. Eur. J. Cancer 40, 2324-2330
Purkrábková T., Smetana K. Jr., Dvoránková B., Holíková Z., Böck C., Lensch M., André S., Pytlík R., Liu F.T., Klíma J., Smetana K., Motlík J. and Gabius H-J. (2003). New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: biotinylated galectins as tool to detect specific binding sites. Biol. Cell 95, 535-545
Rappl G., Abken H., Much J.M., Sterry W., Tilgen W., Ugurel S. and Reinhold U. (2002). CD4+CD7-leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death. Leukemia 16, 840-845
Rorive S., Belot N., Decaestecker C., Lefranc F., Gordower L., Micik S., Maurage C.A., Kaltner H., Ruchoux M.M., Danguy A., Gabius H-J., Salmon I., Kiss R. and Camby I. (2001). Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma. Glia 33, 241-255
Saussez S., Nonclerq D., Laurent G., Wattiez R., André S., Kaltner H., Gabius H-J., Kiss R. and Toubeau G. (2005). Toward functional glycomics by localization of tissue lectins: immunohistochemical galectin fingerprinting during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster. Histochem. Cell Biol. 123, 29-41
Saussez S., Cucu D-R., Decaestecker C., Chevalier D., Kaltner H., André S., Wacreniez A., Toubeau G., Camby I., Gabius H-J. and Kiss R. (2006a). Galectin-7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Ann. Surg. Oncol. 13, 999-1009
Saussez S., Lorfevre F., Nonclerq D., Laurent G., André S., Journé F., Kiss R., Toubeau G. and Gabius H-J. (2006b). Toward functional glycomics by localization of binding sites for tissue lectins: lectin histochemical reactivity for galectins during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster. Histochem. Cell Biol. 126, 57-69
Saussez S., Decaestecker C., Lorfevre F., Cucu D-R., Mortuaire G., Chevalier D., Wacreniez A., Kaltner H., André S., Toubeau G., Camby I., Gabius H-J. and Kiss R. (2007). High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas. Int. J. Oncol. 30, 1109-1117
Saussez S., Decaestecker C., Lorfevre F., Chevalier D., Mortuaire G., Kaltner H., André S., Toubeau G., Gabius H-J. and Leroy X. (2008a). Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology 52, 483-493
Saussez S., Decaestecker C., Mahillon V., Cludts S., Capouillez A., Chevalier D., Vet H.K., André S., Toubeau G., Leroy X. and Gabius H.J. (2008b). Galectin-3 upregulation during tumor progression in head and neck cancer. Laryngoscope 118, 1583-1590.
Seifert G. (1996). Warthin Tumoren (Adenolymphome). In: Oralpathologie I, Pathologie der Speicheldrüsen. Doerr W., Seifert G. and Uehlinger E. (eds). Springer. Berlin, Heidelberg, New York. pp. 440-463.
Simpson R.H.W. and Eveson J.W. (2005). World Health Organization Classification of Tumours Pathology & Genetics, Head and Neck Tumours. IARC, Lyon, pp. 263-265.
Smetana K. Jr., Dvofiánková B., Chovance M., Boucek J., Klíma J., Motlík J., Lensch M., Kaltner H., André S. and Gabius H-J. (2006). Nuclear presence of adhesion/growth-regulatory galectins in normal/malignant cells of squamous epithelial origin. Histochem. Cell. Biol. 125, 171-182.
Teymoortash A. and Werner J.A. (2005). Tissue that has lost its track: Warthin's tumour. Virchows Arch 446, 585-588
Teymoortash A., Pientka A., Schrader C., Tiemann M. and Werner J.A. (2006). Expression of galectin-3 in adenoid cystic carcinoma of the head and neck and ist relationship with distant metastasis. J. Cancer Res. Clin. Oncol. 132, 51-56.
Xu X.C., Sola Gallego J.J., Lotan R. and El-Naggar A.K. (2000). Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms. Int. J. Oncol. 17, 271-276
